微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 90.54% | 6.08% | 4.93% | 3/158 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 86.29% | 4.45% | 0.39% | 11/158 | 51.8% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 85.95% | 5.82% | 0.33% | 11/158 | 22.73% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 85.67% | 7.29% | 0.38% | 12/158 | 33.18% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 85.35% | 10.35% | 3.32% | 9/158 | 51.56% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 82.61% | 7.19% | 1.7% | 16/158 | 51.38% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 81.23% | 4.92% | 1.72% | 21/158 | 32.56% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 79.85% | 7.19% | 3.23% | 23/158 | 38.45% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 77.35% | -13.69% | 0.36% | 27/158 | 52.78% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 77.07% | -17.75% | -0.45% | 27/158 | 53.66% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 77.42% | 2% | 3.93% | 28/158 | 6.2% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 74.49% | 2% | -20.5% | 35/158 | 21.37% | 迈威生物 | 99.44% | 行业排名> |
| 2021-12-31 | 93.7% | 100.33% | 4.56% | 5/158 | 55.1% | 迈威生物 | 98.57% | 行业排名> |
| 2021-03-31 | 89.62% | 2% | 100.31% | 7/158 | 53.99% | 首药控股 | 99.93% | 行业排名> |
| 2020-12-31 | -28737.18% | 83.33% | 83.33% | 143/158 | -145.9% | 艾力斯 | 99.41% | 行业排名> |
| 2019-12-31 | -172440.2% | -403.28% | -403.28% | 135/158 | -1222.98% | 艾力斯 | 98.7% | 行业排名> |
| 2018-12-31 | -34263.36% | 2% | 2% | 133/158 | -208.09% | 艾力斯 | 99.4% | 行业排名> |